MEET THE MINIMED™ 630G SYSTEM
Only the MiniMed system has SmartGuard technology, which takes action for you if your sensor glucose values go below a preset level.*
This feature automatically calculates and recommends precise bolus doses and helps you avoid insulin stacking.**
The pump lets you know up to 30 minutes ahead if you’re trending high or low, so you can act sooner to keep your glucose levels where you want them.
The sensor wirelessly sends glucose information to your pump every five minutes, so you can see how you’re doing, spot trends and make adjustments.
* CGM uses a special sensor to measure sugar levels just below the skin known as interstitial fluid. These sensor glucose (SG) values are different from blood glucose (BG) measurements using a BG meter. Sensor glucose values should not be used to make treatment decisions. Patients should always do a BG fingerstick before they make treatment decisions.
** The Bolus Wizard calculator does not account for manual injections and could prompt you to deliver more insulin than needed. Too much insulin may cause hypoglycemia. Consult with your healthcare professional for how long you need to wait after a manual injection before you can rely on the active insulin calculation of your Bolus Wizard calculator.
OTHER BENEFITS OF THE
MINIMED 630G INSULIN PUMP
User-friendly, waterproof§ designWaterproof protection.
Color screen with auto-brightness.
Easy-to-use menu and buttons.
Greater convenienceSimplified, intuitive navigation.
Preset bolus and temp basal options
New redesigned home screen with icons and quick links.
Fewer shotsSmall device worn on your body that continuously delivers insulin.
Tubing changes needed only every two or three days.
§ The MiniMed™ 630G insulin pump is waterproof in up to 3.6 meters (12 feet) of water for up to 24 hours. The Guardian™ Link transmitter is waterproof in up to 2.4 meters (8 feet) of water for up to 30 minutes. See product user guide for care instructions to help maintain waterproof.
EXCLUSIVE SMARTGUARD TECHNOLOGY FOR BETTER GLUCOSE CONTROL
reduced up to 54%*
reduced up to 41%*
reduced up to 54%*
1. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in Type 1 diabetes. Diabetes Care. 1996;19:324–327.
*, 2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
START TODAY WITH THE NEW MINIMED
630G INSULIN PUMP